NCT05976061

Brief Summary

This study evaluates the implementation of the General Practitioners guidelines 'Suspicious Skin Lesions' and investigated whether their publication and implementation has led to a reduction in the proportion of referrals of low-risk patients with actinic keratosis to secondary care, after publication of the General Practitioners guidelines and implementation activities.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
3,379

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2023

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 4, 2023

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2023

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

April 4, 2025

Status Verified

April 1, 2025

Enrollment Period

2.5 years

First QC Date

July 20, 2023

Last Update Submit

April 2, 2025

Conditions

Keywords

General Practitioners guidelinesactinic keratosisgeneral physiciandermatologylow-risk patientsreferrals

Outcome Measures

Primary Outcomes (1)

  • Change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients.

    The change in proportion of low-risk actinic keratosis patients among all actinic keratosis patients referred by the general practitioner to the dermatologist. The definition of low-risk actinic keratosis patients was based on the General Practitioners guidelines 'Suspicious skin lesions' (published in 2017). Patients were defined as low-risk when they were not immunocompromised, did not have a cutaneous malignancy in their medical history, did not have previous treatment or if they did not have extensive lesions.

    2018 compared to 2019 (2 years)

Study Arms (2)

Low risk patients

Low risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.

High risk patients

High risk actinic keratosis patients referred by the general practitioner and diagnosed as actinic keratosis by the dermatologist in 2018 and 2019.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Data from patients are collected retrospectively using the Electronic health records. Patients were selected based on the diagnosis-treatment-combination (DTC) 17 (premalignant lesion) and DTC 14 (cutaneous malignancy) that was registered from January 2018 to December 2019 by the dermatologist.

You may qualify if:

  • patients of 18 years and older
  • referred to dermatologist for suspicion of actinic keratosis and diagnosed as actinic keratosis by the dermatologist
  • treated at MaastrichtUMC+ or TergooiHospital

You may not qualify if:

  • different diagnosis than actinic keratosis
  • referred by a different specialist than the general practitioner
  • referred with multiple problems
  • referred for a second opinion
  • if the patients was treated as different diagnosis than actinic keratosis by general practitioner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ellen Oyen

Maastricht, Netherlands

Location

Related Links

MeSH Terms

Conditions

Keratosis, Actinic

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsKeratosisSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Klara Mosterd, prof.dr.

    Maastricht UMC+

    PRINCIPAL INVESTIGATOR
  • Maud Jansen, dr.

    Maastricht UMC+

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 20, 2023

First Posted

August 4, 2023

Study Start

March 1, 2021

Primary Completion

September 1, 2023

Study Completion

December 1, 2025

Last Updated

April 4, 2025

Record last verified: 2025-04

Locations